Joseph J. Grano Jr.

Insider · Director · VIRT

Joseph J. Grano Jr. files insider transactions with the SEC as a director of Virtu Financial (VIRT). We hold 1 disclosed purchase or sale filed since 2 February 2006, 1 of them in the last 90 days.

Files forVIRT
Disclosed buys and sells1 in all, 1 in the last 90 days
Last disclosure20 August 2026

Positions held

7 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 1 July 2021 — 19 August 2026Director · Virtu Financial (VIRT)19 Form 4 lines · source: SEC Form 4
Filed 22 June 2017 — 3 February 2020Director · Aevi Genomic Medicine (GNMX)18 Form 4 lines · source: SEC Form 4
Filed 9 February 2015 — 25 January 2017CEO and Chairman · root9B Technologies (RTNB)17 Form 4 lines · source: SEC Form 4
Filed 12 April 2013 — 8 December 2016Director · Medgenics (MDGN)8 Form 4 lines · source: SEC Form 4
Filed 1 July 2013 — 21 October 2014CEO / Chairman · Premier Alliance Group (PIMO)15 Form 4 lines · source: SEC Form 4
Filed 1 February 2006 — 16 January 2008Other role · Amerityre (AMTY)28 Form 4 lines · source: SEC Form 4
Filed 17 March 2005 — 3 April 2007Other role · United Energy Corp /nv/ (UNRG)10 Form 4 lines · source: SEC Form 4

Everything they disclosed

115 entries, newest first — one per disclosure report, one per Form 4 line

▼ sold on the open market 8,400 shares of Virtu FinancialSEC Form 420 August 2026Class A common stock · traded 19 August 2026 · filed 20 August 2026
exercised options over 3,392 shares of Virtu FinancialSEC Form 46 July 2026Class A common stock · traded 1 July 2026 · filed 6 July 2026
exercised options over 3,392 shares of Virtu Financial (a derivative holding)SEC Form 46 July 2026Restricted Stock Unit · traded 1 July 2026 · filed 6 July 2026
was granted 2,504 shares of Virtu Financial (a derivative holding)SEC Form 46 July 2026Restricted Stock Unit · traded 1 July 2026 · filed 6 July 2026
was granted 3,392 shares of Virtu Financial (a derivative holding)SEC Form 43 July 2025Restricted Stock Unit · traded 1 July 2025 · filed 3 July 2025
exercised options over 6,681 shares of Virtu Financial (a derivative holding)SEC Form 43 July 2025Restricted Stock Unit · traded 3 July 2025 · filed 3 July 2025
exercised options over 6,681 shares of Virtu FinancialSEC Form 43 July 2025Class A common stock · traded 3 July 2025 · filed 3 July 2025
exercised options over 8,760 shares of Virtu Financial (a derivative holding)SEC Form 43 July 2024Restricted Stock Unit · traded 3 July 2024 · filed 3 July 2024
was granted 6,681 shares of Virtu Financial (a derivative holding)SEC Form 43 July 2024Restricted Stock Unit · traded 3 July 2024 · filed 3 July 2024
exercised options over 8,760 shares of Virtu FinancialSEC Form 43 July 2024Class A common stock · traded 3 July 2024 · filed 3 July 2024
exercised options over 6,365 shares of Virtu Financial (a derivative holding)SEC Form 43 July 2023Restricted Stock Unit · traded 1 July 2023 · filed 3 July 2023
was granted 8,760 shares of Virtu Financial (a derivative holding)SEC Form 43 July 2023Restricted Stock Unit · traded 1 July 2023 · filed 3 July 2023
exercised options over 6,365 shares of Virtu FinancialSEC Form 43 July 2023Class A common stock · traded 1 July 2023 · filed 3 July 2023
exercised options over 4,880 shares of Virtu Financial (a derivative holding)SEC Form 41 July 2022Restricted Stock Unit · traded 1 July 2022 · filed 1 July 2022
was granted 6,365 shares of Virtu Financial (a derivative holding)SEC Form 41 July 2022Restricted Stock Unit · traded 1 July 2022 · filed 1 July 2022
exercised options over 4,880 shares of Virtu FinancialSEC Form 41 July 2022Class A common stock · traded 1 July 2022 · filed 1 July 2022
exercised options over 5,811 shares of Virtu Financial (a derivative holding)SEC Form 42 July 2021Restricted Stock Unit · traded 1 July 2021 · filed 2 July 2021
was granted 4,880 shares of Virtu Financial (a derivative holding)SEC Form 42 July 2021Restricted Stock Unit · traded 1 July 2021 · filed 2 July 2021
exercised options over 5,811 shares of Virtu FinancialSEC Form 42 July 2021Class A common stock · traded 1 July 2021 · filed 2 July 2021
returned to the issuer 15,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 45 February 2020Stock Option (Right to Purchase) · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 20,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 45 February 2020Stock Option (Right to Purchase) · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 20,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 45 February 2020Stock Option (Right to Purchase) · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 50,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 45 February 2020Stock Option (Right to Purchase) · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 20,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 45 February 2020Stock Option (Right to Purchase) · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 7,061 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 45 February 2020Warrant (Right to Buy) · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 75,683 shares of Aevi Genomic MedicineSEC Form 45 February 2020Common Stock · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 27,000 shares of Aevi Genomic MedicineSEC Form 45 February 2020Common Stock · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 56,780 shares of Aevi Genomic MedicineSEC Form 45 February 2020Common Stock · traded 3 February 2020 · filed 5 February 2020
returned to the issuer 15,384 shares of Aevi Genomic MedicineSEC Form 45 February 2020Common Stock · traded 3 February 2020 · filed 5 February 2020
▲ bought on the open market 26,000 shares of Aevi Genomic MedicineSEC Form 413 November 2018Common Stock · traded 7 November 2018 · filed 13 November 2018
▲ bought on the open market 21,000 shares of Aevi Genomic MedicineSEC Form 413 November 2018Common Stock · traded 7 November 2018 · filed 13 November 2018
▲ bought on the open market 21,000 shares of Aevi Genomic MedicineSEC Form 413 November 2018Common Stock · traded 7 November 2018 · filed 13 November 2018
was granted 50,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 418 July 2018Stock Option (Right to Purchase) · traded 14 June 2018 · filed 18 July 2018
was granted 50,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 418 June 2018Stock Option (Right to Purchase) · traded 14 June 2018 · filed 18 June 2018
▲ bought on the open market 39,683 shares of Aevi Genomic MedicineSEC Form 418 October 2017Common Stock · traded 17 October 2017 · filed 18 October 2017
▲ bought on the open market 7,061 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 418 October 2017Warrant (right to buy) · traded 17 October 2017 · filed 18 October 2017
was granted 20,000 shares of Aevi Genomic Medicine (a derivative holding)SEC Form 410 August 2017Option Award (right to buy) · traded 22 June 2017 · filed 10 August 2017
▲ bought on the open market 20,833 shares of root9B Holdings (a derivative holding)SEC Form 427 January 2017Convertible Promissory Note · traded 25 January 2017 · filed 27 January 2017
▲ bought on the open market 10,416 shares of root9B Holdings (a derivative holding)SEC Form 427 January 2017Common Stock Purchase Warrant · traded 25 January 2017 · filed 27 January 2017
▲ bought on the open market 3,000 shares of MedgenicsSEC Form 412 December 2016Common Stock · traded 8 December 2016 · filed 12 December 2016
returned to the issuer 1,036,842 shares of root9B Technologies (a derivative holding)SEC Form 416 November 2016Options (right to buy) · traded 14 November 2016 · filed 16 November 2016
was granted 528,789 shares of root9B Technologies (a derivative holding)SEC Form 416 November 2016Options (right to buy) · traded 14 November 2016 · filed 16 November 2016
was granted 20,000 shares of Medgenics (a derivative holding)SEC Form 419 April 2016Option Award (right to buy) · traded 15 April 2016 · filed 19 April 2016
▲ bought on the open market 15,384 shares of MedgenicsSEC Form 48 October 2015Common Stock · traded 6 October 2015 · filed 8 October 2015
exercised options over 655,738 shares of root9B TechnologiesSEC Form 424 August 2015common stock, par value $.001 · traded 21 August 2015 · filed 24 August 2015
exercised options over 655,738 shares of root9B Technologies (a derivative holding)SEC Form 424 August 2015option to purchase (common stock, par value $.001) · traded 21 August 2015 · filed 24 August 2015
exercised options over 263,158 shares of root9B TechnologiesSEC Form 424 August 2015common stock,par value $.001 · traded 21 August 2015 · filed 24 August 2015
exercised options over 263,158 shares of root9B Technologies (a derivative holding)SEC Form 424 August 2015option to purchase (common stock, par value $.001) · traded 21 August 2015 · filed 24 August 2015
▲ bought on the open market 100 shares of root9B TechnologiesSEC Form 426 June 2015common stock, par value $.001 · traded 25 June 2015 · filed 26 June 2015
▲ bought on the open market 1,900 shares of root9B TechnologiesSEC Form 426 June 2015common stock, par value $.001 · traded 25 June 2015 · filed 26 June 2015
▲ bought on the open market 98,000 shares of root9B TechnologiesSEC Form 426 June 2015common stock, par value $.001 · traded 25 June 2015 · filed 26 June 2015
▲ bought on the open market 3,675 shares of root9B TechnologiesSEC Form 44 May 2015common stock, par value $.001 · traded 30 April 2015 · filed 4 May 2015
▲ bought on the open market 45,400 shares of root9B TechnologiesSEC Form 44 May 2015common stock, par value $.001 · traded 30 April 2015 · filed 4 May 2015
▲ bought on the open market 5,925 shares of root9B TechnologiesSEC Form 44 May 2015common stock, par value $.001 · traded 30 April 2015 · filed 4 May 2015
▲ bought on the open market 2,000 shares of root9B TechnologiesSEC Form 41 May 2015common stock, par value $.001 · traded 30 April 2015 · filed 1 May 2015
▲ bought on the open market 55,000 shares of root9B TechnologiesSEC Form 41 May 2015common stock, par value $.001 · traded 30 April 2015 · filed 1 May 2015
was granted 20,000 shares of Medgenics (a derivative holding)SEC Form 420 February 2015Option Award (right to buy) · traded 18 February 2015 · filed 20 February 2015
acquired or disposed of, other 457,220 shares of root9B TechnologiesSEC Form 411 February 2015Common Stock, par value $.001 · traded 9 February 2015 · filed 11 February 2015
▲ bought on the open market 48,780 shares of MedgenicsSEC Form 42 December 2014Common Stock · traded 1 December 2014 · filed 2 December 2014
▲ bought on the open market 44,400 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 5,000 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 15,600 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 10,000 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 5,000 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 1,939 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 3,061 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 5,000 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 4,900 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 5,000 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 100 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
▲ bought on the open market 5,000 shares of Premier Alliance GroupSEC Form 422 October 2014common stock, par value $.001 · traded 21 October 2014 · filed 22 October 2014
was granted 250,000 shares of Premier Alliance Group (a derivative holding)SEC Form 418 June 2014Options (Right to Buy) · traded 3 March 2014 · filed 18 June 2014
was granted 2,000,000 shares of Premier Alliance Group (a derivative holding)SEC Form 418 June 2014Options (Right to Buy) · traded 20 May 2014 · filed 18 June 2014
was granted 7,000 shares of MedgenicsSEC Form 46 January 2014Common Stock · traded 2 January 2014 · filed 6 January 2014
was granted 15,000 shares of Medgenics (a derivative holding)SEC Form 46 January 2014Option Award (right to buy) · traded 2 January 2014 · filed 6 January 2014
was granted 75,000 shares of Premier Alliance Group (a derivative holding)SEC Form 425 July 2013Options (Right to Buy) · traded 1 July 2013 · filed 25 July 2013
was granted 300,000 shares of Medgenics (a derivative holding)SEC Form 416 April 2013Option Award (right to buy) · traded 12 April 2013 · filed 16 April 2013
▼ sold on the open market 15,000 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 3 July 2007 · filed 17 January 2008
▼ sold on the open market 10,000 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 3 July 2007 · filed 17 January 2008
▼ sold on the open market 6,310 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 26 November 2007 · filed 17 January 2008
▼ sold on the open market 6,190 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 27 November 2007 · filed 17 January 2008
▼ sold on the open market 9,700 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 28 November 2007 · filed 17 January 2008
▼ sold on the open market 2,800 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 29 November 2007 · filed 17 January 2008
▼ sold on the open market 10,781 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 4 January 2008 · filed 17 January 2008
▼ sold on the open market 3,130 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 7 January 2008 · filed 17 January 2008
▼ sold on the open market 7,000 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 8 January 2008 · filed 17 January 2008
▼ sold on the open market 8,242 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 9 January 2008 · filed 17 January 2008
▼ sold on the open market 6,367 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 10 January 2008 · filed 17 January 2008
▼ sold on the open market 6,167 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 11 January 2008 · filed 17 January 2008
▼ sold on the open market 6,733 shares of AmerityreSEC Form 417 January 2008Common Stock · traded 16 January 2008 · filed 17 January 2008
▼ sold on the open market 10,781 shares of AmerityreSEC Form 416 January 2008Common Stock · traded 4 January 2008 · filed 16 January 2008
▼ sold on the open market 3,130 shares of AmerityreSEC Form 416 January 2008Common Stock · traded 7 January 2008 · filed 16 January 2008
▼ sold on the open market 7,000 shares of AmerityreSEC Form 416 January 2008Common Stock · traded 8 January 2008 · filed 16 January 2008
▼ sold on the open market 8,242 shares of AmerityreSEC Form 416 January 2008Common Stock · traded 9 January 2008 · filed 16 January 2008
▼ sold on the open market 6,367 shares of AmerityreSEC Form 416 January 2008Common Stock · traded 10 January 2008 · filed 16 January 2008
▼ sold on the open market 6,167 shares of AmerityreSEC Form 416 January 2008Common Stock · traded 11 January 2008 · filed 16 January 2008
▼ sold on the open market 15,000 shares of AmerityreSEC Form 44 December 2007Common Stock · traded 3 July 2007 · filed 4 December 2007
▼ sold on the open market 10,000 shares of AmerityreSEC Form 44 December 2007Common Stock · traded 3 July 2007 · filed 4 December 2007
▼ sold on the open market 6,310 shares of AmerityreSEC Form 44 December 2007Common Stock · traded 26 November 2007 · filed 4 December 2007
▼ sold on the open market 6,190 shares of AmerityreSEC Form 44 December 2007Common Stock · traded 27 November 2007 · filed 4 December 2007
▼ sold on the open market 9,700 shares of AmerityreSEC Form 44 December 2007Common Stock · traded 28 November 2007 · filed 4 December 2007
▼ sold on the open market 2,800 shares of AmerityreSEC Form 44 December 2007Common Stock · traded 29 November 2007 · filed 4 December 2007
▲ bought on the open market 160,500 shares of United Energy Corp /nv/SEC Form 424 April 2007Common Stock, $0.01 par value · traded 2 August 2006 · filed 24 April 2007
▲ bought on the open market 73,000 shares of United Energy Corp /nv/SEC Form 424 April 2007Common Stock, $0.01 par value · traded 8 March 2007 · filed 24 April 2007
▲ bought on the open market 7,250 shares of United Energy Corp /nv/SEC Form 424 April 2007Common Stock, $0.01 par value · traded 9 March 2007 · filed 24 April 2007
▲ bought on the open market 19,750 shares of United Energy Corp /nv/SEC Form 424 April 2007Common Stock, $0.01 par value · traded 23 March 2007 · filed 24 April 2007
▲ bought on the open market 5,000 shares of United Energy Corp /nv/SEC Form 424 April 2007Common Stock, $0.01 par value · traded 28 March 2007 · filed 24 April 2007
▲ bought on the open market 1,500 shares of United Energy Corp /nv/SEC Form 424 April 2007Common Stock, $0.01 par value · traded 3 April 2007 · filed 24 April 2007
▲ bought on the open market 1,500 shares of United Energy Corp /nv/SEC Form 416 April 2007Common Stock, $0.01 par value · traded 3 April 2007 · filed 16 April 2007
was granted 8,333 shares of United Energy Corp /nv/ (a derivative holding)SEC Form 42 March 2006Stock Purchase Warrant (right to purchase) · traded 7 April 2005 · filed 2 March 2006
was granted 62,500 shares of United Energy Corp /nv/ (a derivative holding)SEC Form 42 March 2006Stock Purchase Warrant (right to purchase) · traded 17 March 2005 · filed 2 March 2006
▲ bought on the open market 241,666 shares of United Energy Corp /nv/SEC Form 42 March 2006Common Stock, $0.01 par value · traded 26 January 2006 · filed 2 March 2006
▲ bought on the open market 13,190 shares of Amerityre (a derivative holding)SEC Form 42 February 2006Class A Warrants · traded 1 February 2006 · filed 2 February 2006
▲ bought on the open market 13,190 shares of Amerityre (a derivative holding)SEC Form 42 February 2006Class B Warrants · traded 1 February 2006 · filed 2 February 2006
▲ bought on the open market 105,520 shares of AmerityreSEC Form 42 February 2006Common stock · traded 1 February 2006 · filed 2 February 2006

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.